Impaired nitroglycerin biotransformation in patients with chronic heart failure

Clinical Physiology and Functional Imaging

Volumn 28, Issue 4, 2008, Pages 229-234

  Petersson, Magnus ^a   Rundqvist, Bengt ^a   Bennett, Brian M ^b   Adams, Michael A ^b   Friberg, Peter ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Blood pressure; Heart failure; Nitroglycerin; Vasoactive agents; Vasodilation

Indexed keywords

AMIODARONE; ANGIOTENSIN II ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCEROL 1,2 DINITRATE; GLYCEROL 1,3 DINITRATE; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL;

ADULT; ARTICLE; BLOOD PRESSURE; CAPILLARY PRESSURE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE TITRATION; DRUG TRANSFORMATION; HEART CATHETERIZATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LUNG WEDGE PRESSURE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL;

ADULT; BIOTRANSFORMATION; CHRONIC DISEASE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; VASODILATOR AGENTS;

EID: 45549108947     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2008.00793.x     Document Type: Article

References (32)

1. Abrams J. How to use nitrates. Cardiovasc Drugs Ther (2002); 16: 511-514.
2. Armstrong PW, Watts DG, Moffat JA. Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. Br J Clin Pharmacol (1983); 16: 385-390.
3. Bennett BM, Kobus SM, Brien JF, Nakatsu K, Marks GS. Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate. J Pharmacol Exp Ther (1986); 237: 629-635.
4. Bennett BM, Leitman DC, Schröder H, Kawamoto JH, Nakatsu K, Murad F. Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines. J Pharmacol Exp Ther (1989); 250: 316-323.
5. Bennett BM, McDonald BJ, Nigam R, Simon WC. Biotransformation of organic nitrates and vascular smooth muscle cell function. Trends Pharmacol Sci (1994); 15: 245-249.
6. Brien JF, McLaughlin BE, Breedon TH, Bennett BM, Nakatsu K, Marks GS. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta. J Pharmacol Exp Ther (1986); 237: 608-614.
7. Chen Z, Zhang J, Stamler JS. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci U S A (2002); 99: 8306-8311.
8. Cowburn PJ, Cleland JG, McArthur JD, MacLean MR, McMurray JJ, Dargie HJ, Morton JJ. Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction. J Am Coll Cardiol (1999); 33: 932-938.
9. DiFabio J, Ji Y, Vasiliou V, Thatcher GR, Bennett BM. Role of mitochondrial aldehyde dehydrogenase in nitrate tolerance. Mol Pharmacol (2003); 64: 1109-1116.
10. Doel JJ, Godber BL, Goult TA, Eisenthal R, Harrison R. Reduction of organic nitrites to nitric oxide catalyzed by xanthine oxidase: Possible role in metabolism of nitrovasodilators. Biochem Biophys Res Commun (2000); 270: 880-885.
11. Elkayam U, Kulick D, McIntosh N, Roth A, Hsueh W, Rahimtoola SH. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary heart disease and heart failure. Circulation (1987); 76: 577-584.
12. Fung HL, Poliszczuk R. Nitrosothiol and nitrate tolerance. Z Kardiol (1986); 75: 25-27.
13. Habig WH, Keen JH, Jakoby WB. Glutathione S-transferase in the formation of cyanide from organic thiocyantes and as an organic nitrate reductase. Biochem Biophys Res Commun (1975); 64: 501-506.
14. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, LeJemtel TH. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol (1992); 19: 918-925.
15. Lassègue B, Sorescu D, Szöcs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res (2001); 88: 888-894.
16. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1982/5 (1982); 49: 1659-1666.
17. Lopez Farre A, Casado S. Heart failure, redox alterations, and endothelial dysfunction. Hypertension (2001); 38: 1400-1405.
18. Maguire SM, Nugent AG, McGurk C, Johnston GD, Nicholls DP. Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent. Heart (1998); 80: 141-145.
19. McDonald BJ, Bennett BM. Cytochrome P-450 mediated biotransformation of organic nitrates. Can J Physiol Pharmacol (1990); 68: 1552-1557.
20. McGuire JJ, Anderson DJ, Bennett BM. Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate. J Pharmacol Exp Ther (1994); 271: 708-714.
21. McGuire JJ, Anderson DJ, McDonald BJ, Narayanasami R, Bennett BM. Inhibition of NADPH-cytochrome P450 reductase and glyceryl trinitrate biotransformation by diphenyleneiodonium sulfate. Biochem Pharmacol (1998); 56: 881-893.
22. Meah Y, Brown BJ, Chakraborty S, Massey V. Old yellow enzyme: Reduction of nitrate esters, glycerin trinitrate, and propylene 1,2-dinitrate. Proc Natl Acad Sci USA (2001); 98: 8560-8565.
23. Münzel T, Daiber A, Mülsch A. Explaining the phenomenon of nitrate tolerance. Circ Res (2005); 97: 618-628.
24. Nakamura M, Sugawara S, Arakawa N, Nagano M, Shizuka T, Shimoda Y, Sakai T, Hiramori K. Reduced vascular compliance is associated with impaired endothelium-dependent dilatation in the brachial artery of patients with congestive heart failure. J Card Fail (2004); 10: 36-42.
25. Newby DE, Goodfield NE, Flapan AD, Boon NA, Fox KA, Webb DJ. Regulation of peripheral vascular tone in patients with heart failure: Contribution of angiotensin II. Heart (1998); 80: 134-140.
26. Petersson M, Friberg P, Lambert G, Rundqvist B. Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure. Eur J Heart Fail (2005); 7: 1003-1010.
27. Ratz JD, Fraser AB, Rees-Milton KJ, Adams MA, Bennett BM. Endothelin receptor antagonism does not prevent the development of in vivo glyceryl trinitrate tolerance in the rat. J Pharmacol Exp Ther (2000); 295: 578-585.
28. Ratz JD, Adams MA, Bennett BM. Effect of in vivo nitrate tolerance on hypersensitivity to NO donors after NO-synthase blockade. Can J Physiol Pharmacol (2002); 80: 1106-1118.
29. Sage PR, de la Lande IS, Stafford I, Bennett CL, Phillipov G, Stubberfield J, Horowitz JD. Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion. Circulation (2000); 102: 2810-2815.
30. Slack CJ, McLaughlin BE, Brien JF, Marks GS, Nakatsu K. Biotransformation of glyceryl trinitrate and isosorbide dinitrate in vascular smooth muscle made tolerant to organic nitrates. Can J Physiol Pharmacol (1989); 67: 1381-1385.
31. Torfgård KE, Ahlner J, Axelsson KL, Norlander B, Bertler A. Tissue disposition of glyceryl trinitrate, 1,2-glyceryl dinitrate, and 1,3-glyceryl dinitrate in tolerant and nontolerant rats. Drug Metab Dispos (1992); 20: 553-558.
32. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res (2001); 88: 947-953.